LymphaCare Expands by Offering RevitaMed Therapy, a Pain Relieving Therapeutic Device for Home Infrared Therapy Treating Diabetic Neuropathy, Chronic Pain, and Lymphedema

Share Article

New Jersey based LymphaCare, already a national provider of home lymphedema products is now offering RevitaMed Infrared Therapy as part of its product line for circulation disorders. The RevitaMed Infrared System is designed to be the most effective and inexpensive anodyne (pain relieving) infrared device to treat neuropathy and chronic pain.

RevitaMed and LymphaCare are trying to help patients with lymphedema, vascular disease, and diabetic neuropathy see the light, or rather infrared light therapy.

Diabetic neuropathy is a lack of ability to feel vibrations, for example from a tuning fork. This test can be carried out during your regular checkup for diabetes. The same sort of nerve damage can occur in the hands. This is uncommon, and is always accompanied by problems in the feet and legs. Unfortunately, this type of nerve damage is permanent. Once it's happened, it isn't improved by better control of diabetes.

By carrying the RevitaMed, LymphaCare will be able to offer its customers a superior Infrared Therapy device at a low cost they desire. As more patients and facilities look for additional anodyne, or something that provides pain relief therapy, LymphaCare will be able to meet those needs. Offering a more effective and much less expensive alternative to more widely known Anodyne® Therapy ( as part of its product line by carrying the FDA approved RevitaMed system for Infrared Therapy.

LymphaCare is already nationally recognized as a leader in providing patients and clinics with home compression therapy products for lymphedema and venous insufficiency. They are experts in insurance reimbursement and coverage of lymphedema products which are available in all 50 states and internationally.

Lymphedema is the chronic swelling or feeling of tightness in the arm or hand due to an accumulation of lymphatic fluid in the soft tissue of the arm. The condition occurs when lymph vessels, which normally carry excess fluid out of the limbs and back into central circulation, have had their flow interrupted. Axillary (underarm) lymph node removal is commonly performed on breast cancer patients to stage or treat their cancer. However, between 15% and 20% of breast cancer patients who undergo axillary lymph node removal develop lymphedema. According to the American Cancer Society, of the two million breast cancer survivors in the U.S., approximately 400,000 must cope with lymphedema on a daily basis. (

LymphaCare can be reached at 800-288-1801.

# # #

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Adam Anschel
Visit website